Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1991 1
1992 3
1996 4
1997 3
1998 8
1999 7
2000 4
2001 4
2002 5
2003 6
2004 2
2005 6
2006 4
2007 4
2008 11
2009 16
2010 11
2011 19
2012 23
2013 24
2014 26
2015 33
2016 21
2017 25
2018 21
2019 26
2020 35
2021 41
2022 31
2023 35
2024 40
2025 30
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

460 results

Results by year

Filters applied: . Clear all
Page 1
There is an association between gastro-oesophageal reflux and cow's milk protein intolerance.
O'Shea C, Khan R. O'Shea C, et al. Ir J Med Sci. 2022 Aug;191(4):1717-1724. doi: 10.1007/s11845-021-02757-2. Epub 2021 Sep 30. Ir J Med Sci. 2022. PMID: 34590200 Review.
AIMS: Gastro-oesophageal reflux (GOR) and cow's milk protein intolerance (CMPI) are two frequently occurring conditions found in infancy. ...RESULTS: This review revealed varying degrees of co-existence of GOR and CMPI. Iacono et al., Farahmand et al., Kamer et al., …
AIMS: Gastro-oesophageal reflux (GOR) and cow's milk protein intolerance (CMPI) are two frequently occurring conditions found in infa …
[Male osteoporosis].
Farahmand P, Spiegel R, Ringe JD. Farahmand P, et al. Z Rheumatol. 2016 Jun;75(5):459-65. doi: 10.1007/s00393-016-0078-2. Z Rheumatol. 2016. PMID: 27117306 Review. German.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
BACKGROUND: Evobrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has shown preliminary efficacy in people with relapsing multiple sclerosis in a phase 2 trial. ...Three people who received evobrutinib and one who received teriflunomide met the biochemical definition of …
BACKGROUND: Evobrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has shown preliminary efficacy in people with relapsing multiple …
Response to Farahmand and Maibach's corrigenda.
Kissel JC, Bunge AL. Kissel JC, et al. Int J Pharm. 2010 Oct 15;398(1-2):254-6. doi: 10.1016/j.ijpharm.2010.06.024. Epub 2010 Jun 19. Int J Pharm. 2010. PMID: 20600728 No abstract available.
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diarrhoeal Diseases Collaborators. GBD 2021 Diarrhoeal Diseases Collaborators. Lancet Infect Dis. 2025 May;25(5):519-536. doi: 10.1016/S1473-3099(24)00691-1. Epub 2024 Dec 18. Lancet Infect Dis. 2025. PMID: 39708822 Free PMC article.
460 results